Trial record 1 of 1 for:
MT14-AU18LCL209
Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Lateral Canthal Lines
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04143854 |
|
Recruitment Status :
Completed
First Posted : October 29, 2019
Last Update Posted : March 19, 2021
|
Sponsor:
Medy-Tox
Information provided by (Responsible Party):
Medy-Tox
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | August 19, 2020 |
| Actual Study Completion Date : | August 19, 2020 |